Penumbra, Inc. (PEN)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 208.68 |
| Open | 208.15 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 200.96 - 208.60 |
| 52-week range | 180.93 - 348.67 |
| Volume | |
| Avg. volume | 337,204 |
| Market cap | 7.812B |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | 87.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Here's Why You Should Retain Penumbra (PEN) Stock for Now
Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
- GuruFocus.com
Insider Sell: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...
Penumbra Inc (NYSE:PEN), a global healthcare company focused on innovative therapies, has seen a recent insider transaction according to the latest SEC filings.
- Simply Wall St.
Are Penumbra, Inc.'s (NYSE:PEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
It is hard to get excited after looking at Penumbra's (NYSE:PEN) recent performance, when its stock has declined 13...
© 2024 Yahoo. All rights reserved.